Blackwell moved to the UK in 1975 and worked at the London School of Hygiene & Tropical Medicine for 17 years. She was funded by a Wellcome Trust Senior Fellowship until 1991.[5] In 1991 Blackwell joined the University of Cambridge, where she raised money to develop the Cambridge Institute for Medical Research as the Glaxo Professor of Molecular Parasitology.[1] She chaired the World Health Organization Leishmania Genome Consortium between 1992 and 2003.[5][6][7] As part of the Wellcome Trust Case-Control Consortium she discovered that HLA alleles regulating cell-mediated immunity are major genetic risk factors for visceral leishmaniasis, a factor that could be important in genome-based vaccine development.[8] She contributed to several books and review papers on genomics and leishmaniasis.[9][10][11][12][13]
She returned to University of Western Australia in 2007, where she established a genetics laboratory at the The Kids Research Institute Australia.[5][14] Here she has undertaken genetic and functional studies of otitis media, rare genetic diseases, rheumatic heart disease, congenital infections, metabolic diseases, including in aboriginal populations.[5] She identified genetic risk factors for high BMI, rheumatic heart disease and Type 2 Diabetes amongst aboriginal communities.[15][16]
^Blackwell, Jenefer M. (1 March 1997). "Progress in the Leishmania genome project". Transactions of the Royal Society of Tropical Medicine and Hygiene. 91 (2): 107–110. doi:10.1016/S0035-9203(97)90187-5. ISSN0035-9203. PMID9196742.
This article needs additional or more specific categories. Please help out by adding categories to it so that it can be listed with similar articles.(March 2022)
